Free Trial

Baxter International (BAX) Competitors

$35.51
+0.42 (+1.20%)
(As of 07/26/2024 ET)

BAX vs. BDX, EW, DXCM, IDXX, RMD, STE, HOLX, PODD, TFX, and GMED

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk.

Baxter International has a net margin of 17.79% compared to Becton, Dickinson and Company's net margin of 6.76%. Baxter International's return on equity of 18.47% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International17.79% 18.47% 4.91%
Becton, Dickinson and Company 6.76%13.90%6.73%

Baxter International pays an annual dividend of $1.16 per share and has a dividend yield of 3.3%. Becton, Dickinson and Company pays an annual dividend of $3.80 per share and has a dividend yield of 1.6%. Baxter International pays out 22.3% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 83.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Becton, Dickinson and Company had 13 more articles in the media than Baxter International. MarketBeat recorded 20 mentions for Becton, Dickinson and Company and 7 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 0.78 beat Baxter International's score of 0.56 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
7 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International received 136 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.97% of users gave Baxter International an outperform vote while only 62.29% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
729
65.97%
Underperform Votes
376
34.03%
Becton, Dickinson and CompanyOutperform Votes
593
62.29%
Underperform Votes
359
37.71%

Baxter International has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500.

Baxter International presently has a consensus price target of $42.67, suggesting a potential upside of 20.15%. Becton, Dickinson and Company has a consensus price target of $280.13, suggesting a potential upside of 18.02%. Given Baxter International's higher probable upside, analysts clearly believe Baxter International is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Becton, Dickinson and Company
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

90.2% of Baxter International shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 0.3% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Baxter International has higher earnings, but lower revenue than Becton, Dickinson and Company. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$14.81B1.22$2.66B$5.206.83
Becton, Dickinson and Company$19.37B3.54$1.48B$4.5452.28

Summary

Baxter International beats Becton, Dickinson and Company on 11 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$18.10B$3.77B$5.31B$18.50B
Dividend Yield3.27%1.63%2.72%3.51%
P/E Ratio6.8314.77152.0825.04
Price / Sales1.2264.102,071.7415.37
Price / Cash6.7749.5835.8919.61
Price / Book2.134.244.955.08
Net Income$2.66B$2.63M$112.29M$977.27M
7 Day Performance0.45%0.68%2.73%1.57%
1 Month Performance5.97%4.33%6.97%5.69%
1 Year Performance-21.92%13.79%11.22%9.05%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
4.9897 of 5 stars
4.99 / 5 stars
$234.33
+1.4%
$280.14
+19.6%
-16.1%$67.72B$19.37B51.6173,000Upcoming Earnings
Dividend Announcement
Analyst Forecast
Short Interest ↓
EW
Edwards Lifesciences
4.9319 of 5 stars
4.93 / 5 stars
$87.03
-1.1%
$96.13
+10.5%
-31.9%$52.44B$6.00B37.5119,800Earnings Report
Analyst Forecast
Options Volume
Analyst Revision
News Coverage
DXCM
DexCom
4.9794 of 5 stars
4.98 / 5 stars
$112.13
+0.4%
$139.33
+24.3%
-51.0%$44.59B$3.62B72.349,600Earnings Report
Analyst Forecast
News Coverage
Gap Down
IDXX
IDEXX Laboratories
4.2835 of 5 stars
4.28 / 5 stars
$470.41
-1.0%
$586.63
+24.7%
-15.5%$38.85B$3.66B45.5411,000Analyst Forecast
News Coverage
RMD
ResMed
4.2202 of 5 stars
4.22 / 5 stars
$209.63
+1.1%
$202.80
-3.3%
-11.1%$30.80B$4.22B32.2010,140Upcoming Earnings
Analyst Forecast
News Coverage
STE
STERIS
4.2417 of 5 stars
4.24 / 5 stars
$231.70
+1.3%
$241.60
+4.3%
+0.4%$22.90B$5.14B60.6518,179Analyst Forecast
News Coverage
HOLX
Hologic
4.5711 of 5 stars
4.57 / 5 stars
$78.10
-0.4%
$85.55
+9.5%
-4.0%$18.23B$4.03B39.856,990Upcoming Earnings
News Coverage
PODD
Insulet
4.7737 of 5 stars
4.77 / 5 stars
$196.76
+1.3%
$239.18
+21.6%
-31.2%$13.78B$1.70B59.623,000Analyst Forecast
News Coverage
Gap Up
TFX
Teleflex
4.4426 of 5 stars
4.44 / 5 stars
$223.37
+0.4%
$263.14
+17.8%
-14.0%$10.52B$2.97B35.8514,500Upcoming Earnings
GMED
Globus Medical
4.6257 of 5 stars
4.63 / 5 stars
$73.38
-0.1%
$73.30
-0.1%
+15.4%$9.93B$1.90B114.665,000Short Interest ↓

Related Companies and Tools

This page (NYSE:BAX) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners